Radiotherapy combined with immune checkpoint inhibition of CTLA-4 effectively inhibited tumor growth, increased the overall survival of CT26 tumor-bearing mice, and [64Cu]NOTA-CD8a PET identified the responding mice before tumor growth inhibition was evident. Here, CTLA4 is linked to neoplasm.